Provided by Tiger Trade Technology Pte. Ltd.

REMEGEN

78.900
-1.000-1.25%
Volume:3.17M
Turnover:250.29M
Market Cap:44.47B
PE:52.42
High:80.800
Open:79.800
Low:77.250
Close:79.900
52wk High:126.600
52wk Low:63.300
Shares:563.61M
HK Float Shares:208.58M
Volume Ratio:0.85
T/O Rate:1.52%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.505
ROE:45.33%
ROA:3.38%
PB:9.70
PE(LYR):52.42
PS:11.27

Loading ...

China International Capital Corporation Maintains Outperform Rating on REMEGEN, Raises Target Price to HK$133.7

Stock News
·
Apr 03

Lilly's Oral GLP-1 Weight Loss Drug Receives FDA Approval, Offering Daily Pill Alternative to Injections

Deep News
·
Apr 03

RemeGen (SEHK:9995) Is Up 30.0% After New HER2-Low Breast Cancer Approval Has The Bull Case Changed?

Simply Wall St.
·
Apr 03

RemeGen Receives Chinese Regulatory Nod for RC288 Clinical Trial

MT Newswires Live
·
Apr 02

Stock Track | RemeGen Soars 5.07% Intraday Following NMPA Approval for Phase I/IIa Trial of Bispecific ADC RC288

Stock Track
·
Apr 02

RemeGen secures NMPA green light for Phase I/IIa trial of bispecific ADC RC288 targeting PSMA/B7H3

Bulletin Express
·
Apr 01

Remegen Receives Clinical Trial Approval for Bispecific ADC Drug RC288

Stock News
·
Apr 01

RemeGen Returns to Profitability in 2025; Shares Jump 6%

MT Newswires Live
·
Mar 30

Insilico Medicine Soars 15% After Announcing $2.75 Billion Partnership with Eli Lilly

Deep News
·
Mar 30

Stock Track | REMEGEN Soars 10.04% Intraday on Strong Annual Results and Profit Turnaround

Stock Track
·
Mar 30

REMEGEN Shares Surge Over 8% Following Strong Annual Results Showing Profit Turnaround

Stock News
·
Mar 30

Compensation Data Revealed for 68 Pharmaceutical Firms

Deep News
·
Mar 28

Remegen Co.,Ltd. Board Approves Multiple Proposals Including the 2025 General Manager Work Report

Deep News
·
Mar 27

REMEGEN Reports Annual Profit of 710 Million Yuan, Turning Around from Prior Year Loss

Stock News
·
Mar 27

HK Pharma Stocks Gained. CSPC Pharma Up 13%; Lepu Bio Up 7%; Hengrui Pharma And Junshi Bio Up 6%; HBM, Beigene, Sihuan Pharm Up 5%

Tiger Newspress
·
Mar 27

HK Pharma Stocks Gained. XuanzhuBio Up 9%; Xtalpi, Lepu Bio And Ascletis Up 6%; Akeso Up 5%; Skb Bio Up 4%.

Tiger Newspress
·
Mar 26

REMEGEN Shares Climb Over 5% as Disitamab Vedotin Gains Fourth Indication Approval

Deep News
·
Mar 24

HK Pharma Stocks Gained. Wuxi XDC Up 8%; Wuxi AppTec Up 7%; Transthera And HBM Up 5%; Keymed Bio And Innocare Up 4%; Wuxi Bio And Remegen Up 3%

Tiger Newspress
·
Mar 24

Remegen's ADC Therapy Disitamab Vedotin Secures Approval for New Breast Cancer Indication

Stock News
·
Mar 23

Hong Kong Market Rebounds as Tech Stocks Revive Amid Complex Middle East Conflict

Stock News
·
Mar 18